- The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
-
McLachlan CS
- KMID: 2511902
- Clin Hypertens.
- 2020 Apr;26(1):14.
- doi: 10.1186/s40885-020-00147-x
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has... -
- CITED
-
- Close
- SHARE
-
- Close
